BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bunchorntavakul C, Reddy KR. Pruritus in chronic cholestatic liver disease. Clin Liver Dis 2012;16:331-46. [PMID: 22541702 DOI: 10.1016/j.cld.2012.03.010] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
Number Citing Articles
1 Mccoll M, Boozalis E, Aguh C, Eseonu AC, Okoye GA, Kwatra SG. Pruritus in Black Skin: Unique Molecular Characteristics and Clinical Features. Journal of the National Medical Association 2021;113:30-8. [DOI: 10.1016/j.jnma.2020.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
2 Chkheidze R, Joseph R, Burner J, Matevosyan K. Plasma exchange for the management of refractory pruritus of cholestasis: A report of three cases and review of literature: CHKHEIDZE et al. J Clin Apher 2018;33:412-8. [DOI: 10.1002/jca.21573] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
3 Horsley-silva JL, Carey EJ, Lindor KD. Advances in primary sclerosing cholangitis. The Lancet Gastroenterology & Hepatology 2016;1:68-77. [DOI: 10.1016/s2468-1253(16)30010-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 2.2] [Reference Citation Analysis]
4 Patel AD, Katz K, Gordon KB. Cutaneous Manifestations of Chronic Liver Disease. Clin Liver Dis 2020;24:351-60. [PMID: 32620276 DOI: 10.1016/j.cld.2020.04.003] [Reference Citation Analysis]
5 Saadi M, Yu C, Othman MO. A Review of the Challenges Associated with the Diagnosis and Therapy of Primary Sclerosing Cholangitis. J Clin Transl Hepatol 2014;2:45-52. [PMID: 26357617 DOI: 10.14218/JCTH.2013.00021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
6 Al-Azzawi H, Patel R, Sood G, Kapoor S. Plasmapheresis for Refractory Pruritus due to Drug-Induced Cholestasis. Case Rep Gastroenterol 2016;10:814-8. [PMID: 28203129 DOI: 10.1159/000454674] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
7 Sobczak M, Sałaga M, Storr MA, Fichna J. Physiology, signaling, and pharmacology of opioid receptors and their ligands in the gastrointestinal tract: current concepts and future perspectives. J Gastroenterol 2014;49:24-45. [PMID: 23397116 DOI: 10.1007/s00535-013-0753-x] [Cited by in Crossref: 91] [Cited by in F6Publishing: 82] [Article Influence: 10.1] [Reference Citation Analysis]
8 Lia M, Berg T, Weydandt LC, Stepan H. Intrahepatic cholestasis of pregnancy resistant to both therapeutic plasma exchange and albumin dialysis. BMJ Case Rep 2022;15:e246318. [PMID: 35135789 DOI: 10.1136/bcr-2021-246318] [Reference Citation Analysis]
9 Sun S, Dong X. Trp channels and itch. Semin Immunopathol 2016;38:293-307. [PMID: 26385480 DOI: 10.1007/s00281-015-0530-4] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 4.7] [Reference Citation Analysis]
10 Aboeldahab S, Khalil F, Ezz Eldawla R. Clinical and Laboratory Characteristics of Elderly Patients with Pruritus. Clin Cosmet Investig Dermatol 2021;14:1009-15. [PMID: 34408461 DOI: 10.2147/CCID.S322527] [Reference Citation Analysis]
11 Lindor KD, Kowdley KV, Harrison ME; American College of Gastroenterology. ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol. 2015;110:646-59; quiz 660. [PMID: 25869391 DOI: 10.1038/ajg.2015.112] [Cited by in Crossref: 254] [Cited by in F6Publishing: 224] [Article Influence: 36.3] [Reference Citation Analysis]
12 Bunchorntavakul C, Reddy KR. Diagnosis and Management of Overlap Syndromes. Clinics in Liver Disease 2015;19:81-97. [DOI: 10.1016/j.cld.2014.09.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
13 Stremmel W, Lukasova M, Weiskirchen R. The neglected biliary mucus and its phosphatidylcholine content: a putative player in pathogenesis of primary cholangitis-a narrative review article. Ann Transl Med 2021;9:738. [PMID: 33987436 DOI: 10.21037/atm-20-3591] [Reference Citation Analysis]
14 Sałaga M, Sobczak M, Fichna J. Inhibition of proteases as a novel therapeutic strategy in the treatment of metabolic, inflammatory and functional diseases of the gastrointestinal tract. Drug Discovery Today 2013;18:708-15. [DOI: 10.1016/j.drudis.2013.03.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
15 Chovatiya R, Brieva J, Hung A. Dupilumab treatment for cholestatic pruritus. Dermatol Ther 2022;:e15296. [PMID: 34981593 DOI: 10.1111/dth.15296] [Reference Citation Analysis]
16 Esmaeili A, Namazi S. Is melatonin effective for pruritus caused by liver disease? Med Hypotheses 2018;121:177-9. [PMID: 30396475 DOI: 10.1016/j.mehy.2018.10.004] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Fuchs CD, Paumgartner G, Mlitz V, Kunczer V, Halilbasic E, Leditznig N, Wahlström A, Ståhlman M, Thüringer A, Kashofer K, Stojakovic T, Marschall HU, Trauner M. Colesevelam attenuates cholestatic liver and bile duct injury in Mdr2-/- mice by modulating composition, signalling and excretion of faecal bile acids. Gut 2018;67:1683-91. [PMID: 29636383 DOI: 10.1136/gutjnl-2017-314553] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 8.0] [Reference Citation Analysis]
18 Singh S, Talwalkar JA. Primary sclerosing cholangitis: diagnosis, prognosis, and management. Clin Gastroenterol Hepatol. 2013;11:898-907. [PMID: 23454027 DOI: 10.1016/j.cgh.2013.02.016] [Cited by in Crossref: 65] [Cited by in F6Publishing: 48] [Article Influence: 7.2] [Reference Citation Analysis]
19 Meinel K, Szabo D, Dezsofi A, Pohl S, Strini T, Greimel T, Aguiriano-moser V, Haidl H, Wagner M, Schlagenhauf A, Jahnel J. The Covert Surge: Murine Bile Acid Levels Are Associated With Pruritus in Pediatric Autoimmune Sclerosing Cholangitis. Front Pediatr 2022;10:903360. [DOI: 10.3389/fped.2022.903360] [Reference Citation Analysis]
20 Orman ES, Johnson AW, Ghabril M, Sachs GA. Hospice care for end stage liver disease in the United States. Expert Rev Gastroenterol Hepatol 2021;15:797-809. [PMID: 33599185 DOI: 10.1080/17474124.2021.1892487] [Reference Citation Analysis]
21 Gibson B, Williams LA, Marques MB, Pham HP. Therapeutic plasma exchange for intractable pruritus secondary to primary sclerosing cholangitis. J Clin Apheresis 2016;31:495-6. [DOI: 10.1002/jca.21436] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Xie Z, Hu H. TRP Channels as Drug Targets to Relieve Itch. Pharmaceuticals (Basel) 2018;11:E100. [PMID: 30301231 DOI: 10.3390/ph11040100] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 8.8] [Reference Citation Analysis]
23 Flores A, Mayo MJ. Primary biliary cirrhosis in 2014. Curr Opin Gastroenterol. 2014;30:245-252. [PMID: 24671010 DOI: 10.1097/MOG.0000000000000058] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
24 Kumar N, Garg N, Bailey A. Opiate receptor antagonists for treatment of severe pruritus associated with advanced cholestatic liver disease. J Palliat Med. 2013;16:122-123. [PMID: 23391399 DOI: 10.1089/jpm.2012.0452] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
25 Han L, Dong X. Itch mechanisms and circuits. Annu Rev Biophys 2014;43:331-55. [PMID: 24819620 DOI: 10.1146/annurev-biophys-051013-022826] [Cited by in Crossref: 90] [Cited by in F6Publishing: 80] [Article Influence: 11.3] [Reference Citation Analysis]
26 Esmaeili A, Nassiri Toosi M, Taher M, Merat S, Bayani J, Fruzan Karimian Z, Esmaeili A, Moazzami B, Namazi S. A Pilot Randomized, Clinical Trial of the Anti-pruritus Effect of Melatonin in Patients with Chronic Liver Disease. Iran J Pharm Res 2021;20:462-72. [PMID: 34567175 DOI: 10.22037/ijpr.2020.112942.14024] [Reference Citation Analysis]
27 Tarikci N, Kocatürk E, Güngör Ş, Topal IO, Can PÜ, Singer R. Pruritus in Systemic Diseases: A Review of Etiological Factors and New Treatment Modalities. ScientificWorldJournal 2015;2015:803752. [PMID: 26240837 DOI: 10.1155/2015/803752] [Cited by in Crossref: 20] [Cited by in F6Publishing: 14] [Article Influence: 2.9] [Reference Citation Analysis]
28 Bajaj JS, Fagan A, Sikaroodi M, Kakiyama G, Takei H, Degefu Y, Pandak WM, Hylemon PB, Fuchs M, John B, Heuman DM, Gavis E, Nittono H, Patil R, Gillevet PM. Alterations in Skin Microbiomes of Patients With Cirrhosis. Clin Gastroenterol Hepatol 2019;17:2581-2591.e15. [PMID: 30905718 DOI: 10.1016/j.cgh.2019.03.028] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
29 Tian B, Wang XL, Huang Y, Chen LH, Cheng RX, Zhou FM, Guo R, Li JC, Liu T. Peripheral and spinal 5-HT receptors participate in cholestatic itch and antinociception induced by bile duct ligation in rats. Sci Rep 2016;6:36286. [PMID: 27824106 DOI: 10.1038/srep36286] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
30 Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 2014;66:948-83. [PMID: 25073467 DOI: 10.1124/pr.113.008201] [Cited by in Crossref: 402] [Cited by in F6Publishing: 380] [Article Influence: 57.4] [Reference Citation Analysis]
31 Ahmadi S, Karami Z, Mohammadian A, Khosrobakhsh F, Rostamzadeh J. Cholestasis induced antinociception and decreased gene expression of MOR1 in rat brain. Neuroscience 2015;284:78-86. [DOI: 10.1016/j.neuroscience.2014.08.063] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
32 Allen ME, Brown J, Karakas SE, Pollard RB. Refractory AIDS cholangiopathy: metabolic complications and the role of plasmapheresis. AIDS 2013;27:1193-4. [PMID: 23902924 DOI: 10.1097/QAD.0b013e32835f1fd1] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
33 Koofy NE, Yassin N, Okasha S, William H, Elakel W, Elshiwy Y. Evaluation of the role of bile acids and serotonin as markers of pruritus in children with chronic cholestatic liver disease. Arab J Gastroenterol 2021:S1687-1979(21)00020-4. [PMID: 34090830 DOI: 10.1016/j.ajg.2021.04.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Kennedy LL, Hargrove LA, Graf AB, Francis TC, Hodges KM, Nguyen QP, Ueno Y, Greene JF, Meng F, Huynh VD, Francis HL. Inhibition of mast cell-derived histamine secretion by cromolyn sodium treatment decreases biliary hyperplasia in cholestatic rodents. Lab Invest 2014;94:1406-18. [PMID: 25365204 DOI: 10.1038/labinvest.2014.129] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 4.3] [Reference Citation Analysis]